| Q40937866 | (E)-3,5-Dimethyl-1-p-tolyl-4-(p-tolyl-diazen-yl)-1H-pyrazole |
| Q36658226 | 2-(5,6-Diphenyl-1,2,4-triazin-3-yl)aniline. |
| Q44707725 | 3,5-Dimethyl-4-[(E)-(2-nitrophenyl)diazenyl]-1-(2,3,4,5,6-pentafluorophenyl)-1H-pyrazole |
| Q74619427 | 8-Aryl xanthines potent inhibitors of phosphodiesterase 5 |
| Q54753353 | A multicomponent cascade reaction for the synthesis of novel chromenopyranpyrazole scaffolds. |
| Q44257739 | A novel compound JPM8: in vivo penile activity promotion in rats, effect on the relaxation and cGMP/cAMP accumulation in isolated rabbit corpora cavernosa |
| Q44088535 | A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5. |
| Q30836217 | A solid-phase approach towards the synthesis of PDE5 inhibitors |
| Q34491258 | ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association |
| Q35064582 | Advancing drug discovery through systems biology |
| Q95840325 | Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors |
| Q47816035 | Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5. |
| Q50481301 | Catalyst-free, one-pot, three-component synthesis of 5-amino-1,3-aryl-₁Η-pyrazole-4-carbonitriles in green media. |
| Q57017021 | Chemoinformatics and the Quest for Leads in Drug Discovery |
| Q77297316 | Chemotherapeutic potential of phosphodiesterase inhibitors |
| Q37196859 | Cloud infrastructures for in silico drug discovery: economic and practical aspects |
| Q41822316 | Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil |
| Q35900083 | Crystal structure of (2-hy-droxy-5-methyl-phen-yl)(3-methyl-1-phenyl-1H-pyrazolo-[3,4-b]pyridin-5-yl)methanone. |
| Q33630333 | Cyclic GMP phosphodiesterase-5: target of sildenafil |
| Q50202522 | Design, Synthesis and Fungicidal Activity of 2-Substituted Phenyl-2-oxo-, 2-Hydroxy- and 2-Acyloxyethylsulfonamides. |
| Q42048488 | Design, synthesis and biological activity of beta-carboline-based type-5 phosphodiesterase inhibitors |
| Q43620149 | Determination of sildenafil citrate and related substances in the commercial products and tablet dosage form using HPLC. |
| Q43839935 | Determination of transdermal sildenafil in nude mouse skin by reversed-phase high-performance liquid chromatography |
| Q46349856 | Dimers linked by type-I C-F···F-C contacts in (Z)-3-methyl-4-[2-(4-methylphenyl)hydrazinylidene]-1-(pentafluorophenyl)-1H-pyrazol-5(4H)-one |
| Q43839594 | Effect of sildenafil on ocular haemodynamics |
| Q46808109 | Effect of sildenafil on ocular hemodynamics in 3 months regular use. |
| Q46624959 | Effects of sildenafil on blue-on-yellow and white-on-white Humphrey perimetry in 3 months regular use. |
| Q28656104 | Ethics of clinical science in a public health emergency: drug discovery at the bedside |
| Q28362294 | Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil |
| Q77957796 | Imidazo[5,1-f]triazin-4(3H)-ones, a new class of potent PDE 5 inhibitors |
| Q30833986 | In Silico target fishing: addressing a "Big Data" problem by ligand-based similarity rankings with data fusion |
| Q50627316 | In silico design of novel hERG-neutral sildenafil-like PDE5 inhibitors. |
| Q35083854 | Insight into the phosphodiesterase mechanism from combined QM/MM free energy simulations |
| Q51157253 | Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development. |
| Q50200220 | Iodine-catalyzed sulfenylation of pyrazolones using dimethyl sulfoxide as an oxidant |
| Q53614568 | Isolation and identification of a novel sildenafil analogue adulterant in herbal products. |
| Q28138241 | LC/MS applications in drug development |
| Q58126370 | Mini Review: Determination of Sildenafil Citrate in Pharmaceutical Prepaprations |
| Q43545050 | Narrowbore high-performance liquid chromatography for the simultaneous determination of sildenafil and its metabolite UK-103,320 in human plasma using column switching. |
| Q40373695 | Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil |
| Q38815890 | Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors |
| Q43684570 | Phentolamine mesylate relaxes rabbit corpus cavernosum by a nonadrenergic, noncholinergic mechanism |
| Q52682027 | Phosphodiesterase (PDE5) inhibition assay for rapid detection of erectile dysfunction drugs and analogs in sexual enhancement products. |
| Q33964193 | Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies |
| Q34118218 | Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil |
| Q34147460 | Phosphodiesterase 5 inhibitors: current status and potential applications |
| Q35140096 | Phosphodiesterase type 5 (PDE5) inhibitors |
| Q56953149 | Polymer-supported reagents for multi-step organic synthesis: application to the synthesis of sildenafil |
| Q50447605 | Practical synthesis of pyrazoles via a copper-catalyzed relay oxidation strategy |
| Q58136839 | Rapid Resolution RP-HPLC-DAD Method for Simultaneous Determination of Sildenafil, Vardenafil, and Tadalafil in Pharmaceutical Preparations and Counterfeit Drugs |
| Q58237143 | Regiocontrolled Synthesis of Ring-Fused Thieno[2,3-c]pyrazoles through 1,3-Dipolar Cycloaddition of Nitrile Imines with Sulfur-Based Acetylenes |
| Q32185870 | Regioselective synthesis and biological studies of novel 1-aryl-3, 5-bis (het) aryl pyrazole derivatives as potential antiproliferative agents |
| Q78019271 | Retinal side-effects of sildenafil |
| Q34489104 | Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction |
| Q33610343 | Sildenafil (Viagra) for the treatment of erectile dysfunction in men with diabetes |
| Q43601463 | Sildenafil increases diclofenac antinociception in the formalin test |
| Q31415756 | Sildenafil produces antinociception and increases morphine antinociception in the formalin test |
| Q51232624 | Sildenafil vaginal suppositories: preparation, characterization, in vitro and in vivo evaluation. |
| Q43691642 | Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway |
| Q36554423 | Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. |
| Q30835565 | Solid-supported reagents for multi-step organic synthesis: preparation and application. |
| Q53526704 | Stereoselective construction of functionalized tetracyclic and pentacyclic coumarinopyranpyrazole/pyrimidinedione/coumarin scaffolds using a solid-state melt reaction. |
| Q38263672 | Sulfinate derivatives: dual and versatile partners in organic synthesis. |
| Q43552072 | Syntheses and evaluation of pyrido[2,3-dlpyrimidine-2,4-diones as PDE 4 inhibitors |
| Q57744813 | Synthesis and Tautomerism of Substituted Pyrazolo[4,3-c]pyrazoles |
| Q44363691 | Synthesis and biological activities of novel beta-carbolines as PDE5 inhibitors |
| Q43653194 | Synthesis and phosphodiesterase 5 inhibitory activity of new 5-phenyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one derivatives containing an N-acylamido group phenyl ring |
| Q43641509 | Synthesis and phosphodiesterase 5 inhibitory activity of novel phenyl ring modified sildenafil analogues |
| Q43764217 | Synthesis and phosphodiesterase inhibitory activity of new sildenafil analogues containing a carboxylic acid group in the 5'-sulfonamide moiety of a phenyl ring |
| Q39165274 | Synthesis of Functionalized Pyrazoles via 1,3-Dipolar Cycloaddition of α-Diazo-β-ketophosphonates, Sufones and Esters with Electron-Deficient Alkenes |
| Q37521054 | Systems biology in pharmacogenomic research: the way to personalized prescribing? |
| Q43908604 | Tadalafil and vardenafil. |
| Q34266654 | The Discovery of Tadalafil: A Novel and Highly Selective PDE5 Inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1‘,2‘:1,6]pyrido[3,4-b]indole-1,4-dione Analogues |
| Q43732228 | The discovery of novel, potent and selective PDE5 inhibitors |
| Q50255295 | Ultrasonic-accelerated rapid protocol for the improved synthesis of pyrazoles. |
| Q35638042 | Vardenafil treatment for erectile dysfunction |
| Q44366570 | Visual detection of AMP and real-time monitoring of cyclic nucleotide phosphodiesterase (PDE) activity in neutral aqueous solution. Chemosensor-coupled assay of PDE and PDE inhibitors. |
| Q38028518 | When analoging is not enough: scaffold discovery in medicinal chemistry |
| Q50221366 | [3 + 2] cycloaddition and subsequent oxidative dehydrogenation between alkenes and diazo compounds: a simple and direct approach to pyrazoles using TBAI/TBHP. |
| Q37277365 | siRNA Genome Screening Approaches to Therapeutic Drug Repositioning |